FDA Person
FDACara L. Alfaro
View detailed information about Cara L. Alfaro, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 5 inspections of 5 companies, 2016–2026.
Inspections (5)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| July 10, 2026 | Praxis Precision Medicines, Inc. | Not classified | #1332596 | |
| March 27, 2025 | Eli Lilly & Company | Not classified | #1260339 | |
| February 1, 2019 | Nektar Therapeutics | NAI | Bioresearch Monitoring | #1084539 |
| December 8, 2017 | David Kudrow, M.D. | VAI | Bioresearch Monitoring | #1035847 |
| November 18, 2016 | Julio C. Castro-Gayol, M.D. | NAI | Bioresearch Monitoring | #994701 |
Documents (1)
- EIR · Eli Lilly And Company · September 26, 2022
Person Information
Name
Cara L. Alfaro
Title
other
Role
COMPANY REP
ID: cc9fe987-c590-4d06-a1ec-059feab4f5d9
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.